Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5379-5385

  Wada, Hiroko ^a   Enomoto, Takayuki ^a   Fujita, Masami ^a   Yoshino, Kiyoshi ^a   Nakashima, Ryuichi ^a   Kurachi, Hirohisa ^a   Haba, Tomoko ^e   Wakasa, Kenichi ^b   Shroyer, Kenneth R ^d   Tsujimoto, Masahiko ^c   Hongyo, Tadashi ^e   Nomura, Taisei ^a   Murata, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

^d UNIVERSITY OF COLORADO   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOSARCOMA; DNA METHYLATION; GENE MUTATION; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MIXED TUMOR; MOLECULAR BIOLOGY; ONCOGENE K RAS; PATHOGENESIS; PRIORITY JOURNAL; UTERUS TUMOR; X CHROMOSOME INACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA; CARCINOSARCOMA; CODON; DNA METHYLATION; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; EXONS; FEMALE; GENES, P53; GENES, RAS; HUMANS; MIDDLE AGED; MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, ANDROGEN; RESTRICTION MAPPING; SARCOMA; SEQUENCE DELETION; UTERINE NEOPLASMS; X CHROMOSOME;

EID: 15144357228     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Silverberg, S. G., Major, F. J., Blessing, J. A., Fetter, B., Askin, F. B., Liao, S-Y., and Miller, A. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A gynecologic oncology group pathologic study of 203 cases. Int. J. Gynecol. Pathol., 9: 1-19, 1990.
2. Bartsich, E. G., O'Leary, J. A., and Moore, J. G. Carcinosarcoma of uterus. A 50-year review of 32 cases (1917-1966). Obstet. Gynecol., 30: 518-523, 1967.
3. Chung, J. T., Van Velden, D. J. J., and Graham, J. B. Carcinosarcoma and mixed mesodermal tumor of the uterine corpus. Review of 49 cases. Obstet. Gynecol., 35: 769-780, 1970.
4. Clement, P. B., and Scully, R. E. Uterine tumors with mixed epithelial and mesenchymal elements. Semin. Diagn. Pathol., 5: 199-222, 1988.
5. Benediktsdóttir, K. R., Jónasson, J. G., and Hallgrímsson, J. Tumours in Iceland. 12. Malignant tumours of the corpus of the uterus. A histological classification, epidemiological considerations and survival. Acta Pathol. Microbiol. Immunol. Scand., 97: 781-786, 1989.
6. Spanos, W. J., Peters, L. J., and Oswald, M. J. Patterns of recurrence in malignant mixed Müllerian tumor of the uterus. Cancer (Phila.), 57: 155-159, 1986.
7. Williamson, E. O., and Christopherson, W. M. Malignant mixed Müllerian tumors of the uterus. Cancer (Phila.), 29: 585-592, 1972.
8. Silverberg, S. G. Mixed Müllerian tumors. Curr. Top. Pathol., 85: 35-56, 1992.
9. Meyer, R. Mischgeschwülste des Uterus. die komplizieretern tumoren. In: F. Henke and O. Lubarsh (eds.), Handbuch der Speziellen Pathologischen Anatomie und Histolgie, pp. 412-415. Berlin: Julius Springer, 1930.
10. de Brito, P. A., Silverberg, S, G., and Orenstein, J. M. Carcinosarcoma (malignant mixed Müllerian (mesodermal) tumor) of the female genital tract. Immunohistochemical and ultrastructual analysis of 28 cases. Hum. Pathol., 24: 132-142, 1993.
11. Gorai, I., Doi, C., and Minaguchi, H. Establishment and characterization of carcinosarcoma cell line of the human uterus. Cancer (Phila.), 71: 775-786, 1993.
12. Masuda, A., Takeda, A., Fukami, H., Yamada, C., and Matsuyama, M. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells. Cancer (Phila.), 60: 2696-2703, 1987.
13. Emoto, M., Iwasaki, H., Kikuchi, M., Ishiguro, M., Kubota, T., Izumi, H., Shirakawa, K., and Kaneko, Y. Two cell lines established from mixed Müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analyses. Cancer (Phila.), 69: 1759-1768, 1992.
14. Emoto, M., Iwasaki, H., Kikuchi, M., and Shirakawa, K. Characteristics of cloned cells of mixed Müllerian tumor of the human uterus. Carcinoma cells showing myogenic differentiation in vitro. Cancer (Phila.), 71: 3065-3075, 1993.
15. George, E., Manivel, J. C., Dehner, L. P., and Wick, M. R. Malignant mixed Müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. Hum. Pathol., 22: 215-223, 1991.
16. Auerbach, H. E., LiVolsi, V. A., and Merino, M. J. Malignant mixed Müllerian tumors of the uterus. An immunohistochemical study. Int. J. Gynecol. Pathol., 7: 123-130, 1988.
17. Chung, M-T., Mukai, K., Teshima, S., Kishi, K., and Shimosato, Y. Expression of various antigens by different components of uterine mixed Müllerian tumors. An immunohistochemical study. Acta. Pathol. Jpn., 38: 35-45, 1988.
18. Mayall, F., Rutty, K., Campbell, F., and Goddard, H. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal. Histopathology, 24: 211-214, 1994.
19. Meis, J. M., and Lawrence, W. D. The immunohistochemical profile of malignant mixed Müllerian tumor. Overlap with endometrial adenocarcinoma. Am. J. Clin. Pathol., 94: 1-7, 1990.
20. Costa, M. J., Khan, R., and Judd, R. Carcinosarcoma (malignant mixed Müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases. Arch. Pathol. Lab. Med., 115: 583-590, 1991.
21. Emoto, M., Iwasaki, H., Kikuchi, M., and Shirakawa, K. Tissue polypeptide antigen production in a uterine carcinosarcoma cell line in a serum-free culture. Gynecol. Oncol., 60: 443-449, 1996.
22. Kitagawa, K., Murata, A., Matsuura, N., Tohya, K., Takaichi, S., Monden, M., and Inoue, M. Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-β1. Int. J. Cancer, 66: 91-97, 1996.
23. Dahbs, D. J., Sturtz, K., and Zaino, R. J. The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum. Pathol., 27: 172-177, 1996.
24. Farhood, A. I., and Abrams, J. Immunohistochemistry of endometrial stromal sarcoma. Hum. Pathol., 22: 224-230, 1991.
25. Mutter, G. L., and Boynton, K. A. PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies. Nucleic Acids Res., 23: 1411-1418, 1995.
26. Tilley, W. D., Marcelli, M., Wilson, J. D., and McPhaul, M. J. Characterization and expression of a cDNA encoding the human androgen receptor. Proc. Natl. Acad. Sci. USA, 86: 327-331, 1989.
27. Mutter, G. L., Chaponot, M. L., and Fletcher, J. A. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am. J. Pathol., 146: 501-508, 1995.
28. Enomoto, T., Fujita, M., Inoue, M., Tanizawa, O., Nomura, T., and Shroyer, K. R. Analysis of clonality by amplification of short tandem repeats. Carcinomas of the female reproductive tract. Diagn. Mol. Pathol., 3: 292-297, 1994.
29. Allen, R. C., Zoghbi, H. Y., Moseley, A. B., Rosenblatt, H. M., and Belmont, J. W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am. J. Hum. Genet., 51: 1229-1239, 1992.
30. Fujita, M., Inoue, M., Tanizawa, O., Iwamoto, S., and Enomoto, T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papilloma-virus infection. Cancer Res., 52: 5323-5328, 1992.
31. Enomoto, T., Weghorst, C. M., Inoue, M., Tanizawa, O., and Rice, J. M. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am. J. Pathol., 139: 777-785, 1991.
32. Sreenan, J. J., and Hart, W. R. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am. J. Surg. Pathol., 19: 666-674, 1995.
33. Ambros, R. A., Sherman, M. E., Zahn, C. M., Bitterman, P., and Kurman, R. J. Endometrial intraepithelial carcinoma. A distinctive lesion specifically associated with tumors displaying serous differentiation. Hum. Pathol., 26: 1260-1267, 1995.
34. Bitterman, P., Chun, B., and Kurman, R. J. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. Am. J. Surg. Pathol., 14: 317-328, 1990.
35. Morris, H. J., and Taylor, H. B. Mesenchymal tumors of the uterus. III. A clinical and pathologic study of 31 carcinosarcomas. Cancer (Phila.), 19: 1459-1465, 1966.
36. King, M. E., and Kramer, E. E. Malignant Müllerian mixed tumors of the uterus. A study of 21 cases. Cancer (Phila.), 45: 188-190, 1980.
37. Shroyer, K. R., and Gudlaugsson, E. G. Analysis of clonality in archival tissues by polymerase chain reaction amplification of PGK-1. Hum. Pathol., 25: 287-292, 1994.
38. Jovanovic, A. S., Boynton, K. A., and Mutter, G. L. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers. some with microsatellite instability. Cancer Res., 56: 1917-1921, 1996.
39. Thompson, L., Chang, B., and Barsky, S. H. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am. J. Surg. Pathol., 20: 277-285, 1996.
40. Bos, J. L. ras oncogenes in human cancer. A review. Cancer Res., 49: 4682-4689, 1989.
41. Levine, A. J., Monmand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
42. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
43. Enomoto, T., Inoue, M., Perantoni, A. O., Buzard, G. S., Miki, H., Tanizawa, O., and Rice, J. M. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res., 51: 5308-5314, 1991.
44. Enomoto, T., Fujita, M., Inoue, M., Rice, J. M., Nakajima, R., Tanizawa, O., and Nomura, T. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res., 53: 1883-1888, 1993.
45. King, S. A., Adas, A. A., LiVolsi, V. A., Takahashi, H., Behbakht, K. McGovern, P., Benjamin, I., Rubin, S. C., and Boyd, J. Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma. Cancer (Phila.), 75: 2700-2705, 1995.
46. Liu, F-S., Kohler, M. F., Marks, J. R., Bast, R. C., Boyd, J., and Berchuck, A. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Obstet. Gynecol., 83: 118-124, 1994.